摘要
T细胞免疫球蛋白和免疫受体酪氨酸抑制性基序结构域(TIGIT)是一种新的免疫检查点受体,是主要表达于T细胞和自然杀伤细胞(NK细胞)表面的一种免疫抑制性受体,通过抑制T细胞和NK细胞介导的免疫反应影响肿瘤微环境,促进肿瘤的发生发展。本文介绍TIGIT分子的结构与功能,并对TIGIT分子在血液淋巴系统恶性肿瘤的免疫调控、应用和前景作一综述。
T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif domain(TIGIT) is a novel type of immune checkpoint receptor and an immunosuppressive receptor mainly expressed on the cell surface of T cells and NK cells. TIGIT affects the tumor microenvironment and promotes the occurrence and development of tumor by inhibiting the immune response mediated by T cells and NK cells. This paper introduces the structure and function of TIGIT molecule and reviews its immune regulation, application and prospect in hematological malignancies.
作者
王约拿
刘佳
李莉娟
张连生
WANG Yue-na;LIU Jia;LI Li-juan;ZHANG Lian-sheng(Department of Hematology,Lanzhou University Second Hospital,Lanzhou,Gansu 730000,China)
出处
《中国临床研究》
CAS
2022年第6期854-857,共4页
Chinese Journal of Clinical Research